大洋生物股价涨5.86%，鹏华基金旗下1只基金重仓，持有47.16万股浮盈赚取82.53万元

Group 1 - The core viewpoint of the news is that Dayang Bio has seen a significant increase in its stock price, rising by 5.86% to reach 31.61 yuan per share, with a total market capitalization of 2.655 billion yuan [1] - Dayang Bio, established on January 1, 1976, is located in Hangzhou, Zhejiang Province, and was listed on October 26, 2020. The company specializes in the production and sales of chemical raw materials, including inorganic salts and veterinary raw materials [1] - The main revenue composition of Dayang Bio includes 69.91% from inorganic salt products, 18.35% from veterinary raw materials, 7.46% from fluorinated chemicals, and 4.28% from other products [1] Group 2 - From the perspective of fund holdings, one fund under Penghua Fund has a significant position in Dayang Bio. The Penghua Steady Return Mixed A Fund holds 471,600 shares, accounting for 3.43% of the fund's net value, ranking as the tenth largest holding [2] - The Penghua Steady Return Mixed A Fund has a total scale of 327 million yuan and has achieved a return of 88.14% this year, ranking 190 out of 8,155 in its category [2] - The fund manager, Hu Ying, has been in position for 4 years and 52 days, with the best return during this period being 76.27% and the worst being 22.4% [2]